Haggerston BioHealth

• 

  10/4/2024

  **Summit Therapeutics: Cancer Breakthrough Nears US Approval**

• 

  10/4/2024

  **Mirum Pharmaceuticals: Wait for Data Before Buying**

• 

  10/3/2024

  **Arrowhead: First Approval Likely, Investment Verdict Pending**

• 10/2/2024

  **Avidity Biosciences: Compelling Oligonucleotide Program Worth Watching**